Biochem/physiol Actions
Cinaciguat activates sGC (soluble guanylate cyclase) independently of NO. Cinaciguat binds to sGC′s NO-sensory H-NOX domain when it is heme-depleted. Also, the compound Cinaciguat protects sGC from oxidation-induced ubiquitin-triggered degradation.
Cinaciguat, also known as BAY 58-2667, is a novel activator of guanylate cyclase. It is used in the treatment of acute decompensated heart failure (ADHF). It has been reported that cinaciguat possesses cardiovascular effects.
- UPC:
- 51172111
- Condition:
- New
- HazmatClass:
- No
- MPN:
- SML1532-5MG
- CAS:
- 646995-35-9
akash.verma@cenmed.com
(732) 447-1115





